These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3281964)

  • 1. Luteal contraception.
    Kovács L
    Hum Reprod; 1988 Feb; 3(2):169-71. PubMed ID: 3281964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of anti-progesterones as a medical IUD.
    Nieman LK; Loriaux DL
    Baillieres Clin Obstet Gynaecol; 1988 Sep; 2(3):609-16. PubMed ID: 3233821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progesterone antagonists on the horizon.
    Spitz IM; Bardin CW
    Clin Obstet Gynecol; 1989 Jun; 32(2):403-13. PubMed ID: 2663280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of folliculogenesis and ovulation by the antiprogesterone RU 486.
    Luukkainen T; Heikinheimo O; Haukkamaa M; Lähteenmäki P
    Fertil Steril; 1988 Jun; 49(6):961-3. PubMed ID: 3371492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel approach to human fertility control: contragestion by the anti-progesterone RU 486.
    Baulieu EE
    Eur J Obstet Gynecol Reprod Biol; 1988 Jun; 28(2):125-9. PubMed ID: 3402651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiprogesterone activity of RU 486 and its contragestive and other applications.
    Baulieu EE; Ulmann A
    Hum Reprod; 1986 Feb; 1(2):107-10. PubMed ID: 3031127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-coital contraception.
    Haspels AA
    IPPF Med Bull; 1988 Oct; 22(5):1-3. PubMed ID: 12281624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of an antiprogesterone (RU486) on the hypothalamic-hypophyseal-ovarian-endometrial axis during the luteal phase of the menstrual cycle.
    Garzo VG; Liu J; Ulmann A; Baulieu E; Yen SS
    J Clin Endocrinol Metab; 1988 Mar; 66(3):508-17. PubMed ID: 2832438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical use of RU 486: control of the menstrual cycle and effect on the hypophyseal-adrenal axis].
    Gaillard RC; Herrmann W
    Ann Endocrinol (Paris); 1983; 44(5):345-6. PubMed ID: 6675522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mifepristone for luteal phase contraception.
    Croxatto HB
    Contraception; 2003 Dec; 68(6):483-8. PubMed ID: 14698079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiprogesterones.
    Norman J
    Br J Hosp Med; 1991 Jun; 45(6):372-5. PubMed ID: 2070168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the antiprogesterone steroid RU 486 during midluteal phase in normal women.
    Schaison G; George M; Lestrat N; Reinberg A; Baulieu EE
    J Clin Endocrinol Metab; 1985 Sep; 61(3):484-9. PubMed ID: 2991322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The progesterone antagonist RU 486. A potential new contraceptive agent.
    Nieman LK; Choate TM; Chrousos GP; Healy DL; Morin M; Renquist D; Merriam GR; Spitz IM; Bardin CW; Baulieu EE
    N Engl J Med; 1987 Jan; 316(4):187-91. PubMed ID: 3796691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Steroid anti-hormones: anti-progesterone activity of RU 486 and its contragestational and other applications].
    Baulieu EE; Ulmann A
    Bull Acad Natl Med; 1985 Nov; 169(8):1191-9. PubMed ID: 3914335
    [No Abstract]   [Full Text] [Related]  

  • 15. Interception. III: Postcoital luteal contragestion by an antiprogestin (mifepristone, RU 486) in 62 women.
    van Santen MR; Haspels AA
    Contraception; 1987 May; 35(5):423-31. PubMed ID: 3040334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late luteal phase administration of RU486 for three successive cycles does not disrupt bleeding patterns or ovulation.
    Croxatto HB; Salvatierra AM; Romero C; Spitz IM
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1272-7. PubMed ID: 3119656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The possible use of antiprogestins for contraception.
    Bygdeman M; Danielsson KG; Swahn ML
    Acta Obstet Gynecol Scand Suppl; 1997; 164():75-7. PubMed ID: 9225644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mifegyne (mifepristone), a new antiprogestagen with potential therapeutic use in human fertility control.
    Couzinet B; Schaison G
    Drugs; 1988 Mar; 35(3):187-91. PubMed ID: 3286211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of RU486 administered during the proliferative and secretory phase of the cycle on the bleeding pattern, hormonal parameters and the endometrium.
    Swahn ML; Johannisson E; Daniore V; de la Torre B; Bygdeman M
    Hum Reprod; 1988 Oct; 3(7):915-21. PubMed ID: 2846630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fertility control with RU 486.
    Ulmann A; Dubois C; Philibert D
    Horm Res; 1987; 28(2-4):274-8. PubMed ID: 3331378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.